Stockreport

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31 [Canadian Business Journal (Canada)]

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
PDF LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company adv [Read more]